Regeneron Pharmaceuticals, Inc. Common Stock (REGN) - Nasdaq
Discover real-time Regeneron Pharmaceuticals, Inc. Common Stock (REGN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay …
Regeneron Pharmaceuticals, Inc. Common Stock (REGN) Real-Time …
Get real-time updates on Regeneron Pharmaceuticals, Inc. Common Stock (REGN) stock quotes, trades, and more. Make informed investments with Nasdaq.
Regeneron Pharmaceuticals to Report Fourth Quarter and Full
Jan 7, 2025 · Regeneron Pharmaceuticals will share its fourth quarter and full year 2024 financial results, indicating transparency and commitment to informing stakeholders about its performance.
Why Regeneron Pharmaceuticals Stock Topped the Market on …
Feb 4, 2025 · News of a significant earnings beat propelled Regeneron Pharmaceuticals (NASDAQ: REGN) to a nearly 5% share price gain on the second trading day of the week.
Regeneron to Highlight Pioneering Pipeline Progress Across
Nov 13, 2024 · --Regeneron Pharmaceuticals, Inc. today announced new and updated data from its hematology pipeline will be shared across 23 abstracts at the American Society of …
America's Top 40 High School Scientists to Compete for $1.8
Jan 23, 2025 · Regeneron Science Talent Search alumni have gone on to win 13 Nobel Prizes, 23 MacArthur Fellowships, and have founded numerous world-changing companies, including …
REGENERON PHARMACEUTICALS Earnings Results: $REGN …
Feb 4, 2025 · REGENERON PHARMACEUTICALS ($REGN) posted quarterly earnings results on Tuesday, February 4th. The company reported earnings of $12.07 per share, beating …
What 25 Analyst Ratings Have To Say About Regeneron ... - Nasdaq
Dec 17, 2024 · 25 analysts have shared their evaluations of Regeneron Pharmaceuticals (NASDAQ:REGN) during the recent three months, expressing a mix of bullish and bearish …
Regeneron Beats on Q4 Earnings, Initiates Quarterly Dividend
Feb 4, 2025 · Regeneron Pharmaceuticals, Inc. REGN reported fourth-quarter 2024 earnings per share (EPS) of $12.07, which beat the Zacks Consensus Estimate of $11.62. The company …
1 Beaten-Down Stock That Could Soar by 50% in 2025, According …
Jan 2, 2025 · Regeneron's stock could soar by 50% in the next year from its current levels if we go by its average price target of $1,053 (according to Yahoo! Finance).